Table 1.
Expression pattern | |||
---|---|---|---|
+ | +/− | − | |
Verruca vulgaris | 6 | 0 | 3 |
Molluscum contagiosum | 0 | 0 | 7 |
Seborrheic keratosis | 6 | 1 | 3 |
Epidermolytic hyperkeratosis | 0 | 0 | 4 |
Acanthosis nigricans | 0 | 3 | 2 |
Actinic keratosis | 4 | 1 | 0 |
Bowenoid papulosis with high-grade dysplasia, +HPV in situ | 1 | 3 | 7 |
Squamous cell carcinoma in situ, no dermal involvement, sun-exposed sites | 9 | 1 | 3 |
Squamous cell carcinoma, invasion of dermis, both sun-exposed and non-exposed sites | 3 | 1 | 2 |
Basal cell carcinoma | 0 | 0 | 10 |
Pityriasis rubra pilaris | 0 | 1 | 2 |
Psoriasis vulgaris | 5 | 5 | 0 |
Psoriasis pustular | 3 | 0 | 0 |
Psoriasis guttate | 4 | 0 | 0 |
Abbreviation: sAC, soluble adenylyl cyclase.
−: Approximately 10% of keratinocytes have nuclei positive for sAC and sAC staining is strongly cytoplasmic (equivalent to normal skin); +/−: 10–70% of keratinocytes have nuclei positive for sAC and decreased cytoplasmic sAC staining in keratinocytes with sAC nuclear staining; +: >70% of keratinocytes have nuclei positive for sAC, with barely detectable cytoplasmic sAC staining.